Ora Clinical   Report issue

For profit Phase 3 Phase 4
Founded: Andover MA United States (1985)

Organization Overview

First Clinical Trial
2011
NCT01387347
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

Ora Clinical Research and Development

Active Ingredients

Drugs in Phase 4 Trials (2)

menthol (Salonpas) (1 trial)

polyethylene glycol (1 trial)

Drugs in Phase 3 Trials (1)

thymosin beta-4 (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dry Eye Syndromes (Phase 4)

Keratoconjunctivitis Sicca (Phase 4)

Syndrome (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 3